SOFTOX SOLUTIONS
SOFTX
ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE
SoftOx Solutions AS: Notice of General Assembly
SoftOx Solutions AS will hold a General Meeting on 24th June 2026 at 10 am (CEST). The notice convening the General Meeting, including the agenda and the board's proposals for the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders.
Relevant documents referred to in the notice are also made available at https://soft-ox.com/stock-market-announcements/
For further information, please contact: Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87 Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165 Mail: ir@soft-ox.com
About SoftOx Solutions AS: SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company developing SIS (SoftOx Inhalation Solution), a novel inhaled anti-infective therapy for the treatment of respiratory infections in the airways and lungs. The Company is listed on Euronext Growth Oslo.